Delivery Order SPE2DB20D3103-SPE2DB25FP9W3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for Xylocaine-MPF 2% (40 mg/2 mL vials) with a ceiling value of $1,253.12. This non-set-aside, firm fixed-price delivery order is expected to be completed by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement under the federal medical supply chain managed by the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xylocaine-MPF 1% Vial 5ML, a local anesthetic medication commonly used in medical and surgical applications. This firm fixed-price delivery order, valued at $2,413.46, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Xylocaine-MPF 2% 100 mg/5 ml, a local anesthetic medication, with a ceiling value of $1,936.18 and a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Xylocaine-MPF 1% vial 5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,173.76 and is a Firm Fixed Price Delivery Order with a completion date of May 24, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency awarded a delivery order valued at $8,087.53 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 200 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for XYLOCAINE-MPF 2% 100 MG/5 ML 5ML, a pharmaceutical product, with a ceiling value of $2,008.60 and a period of performance through June 11, 2025. The contract is designated as a Firm Fixed Price contract and is not set aside for any specific business category. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,809.06 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 50ML (25 units) with an ultimate completion date of September 29, 2025. This competitive award, issued on September 2, 2025, carries firm fixed pricing and involves no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the headquarters location of AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency Troop Support Medical awarded a $11,230 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562288834 XYLOCAINE MPF 5ML 25S. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by October 23, 2023. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring food,...
- The Defense Logistics Agency awarded a $63,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561832714 XYLOCAINE 1% vials. As the prime contractor, Amerisourcebergen will provide 20mL vials of lidocaine hydrochloride injection, USP 1% to meet requirements under the Agency's pharmaceutical products indefinite-delivery/indefinite-quantity multiple award contract vehicle. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP9W3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,189.69 to AmerisourceBergen Drug Corp for Xylocaine-MPF 2% (40 mg/2 mL vials) on August 22, 2025, with an ultimate completion date of August 25, 2025. This delivery order was competitively awarded without set-aside designation under a firm fixed-price contract structure. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The prime IDC demonstrates AmerisourceBergen Drug Corp's capability to fulfill federal procurement requirements across multiple therapeutic domains and serves customers including the Defense Health Agency and U.S. Coast Guard through flexible delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 8/22/25 |